TRIL, a Functional Component of the TLR4 Signaling Complex, Highly Expressed in Brain
The Journal of Immunology 183(6): 3989-3995
Article 2009 English
Authors
SC
Susan Carpenter
TC
Thaddeus Carlson
JD
Jérôme Dellacasagrande
Abstract
1 min read
TLR4 is the primary sensor of LPS. In this study, we describe for the first time TLR4 interactor with leucine-rich repeats (TRIL), which is a novel component of the TLR4 complex. TRIL is expressed in a number of tissues, most prominently in the brain but also in the spinal cord, lung, kidney, and ovary. TRIL is composed of a signal sequence, 13 leucine-rich repeats, a fibronectin domain, and a single transmembrane spanning region. TRIL is induced by LPS in the human astrocytoma cell line U373, in murine brain following i.p. injection, and in human PBMC. Endogenous TRIL interacts with TLR4 and this interaction is greatly enhanced following LPS stimulation. TRIL also interacts with the TLR4 ligand LPS. Furthermore, U373 cells stably overexpressing TRIL display enhanced cytokine production in response to LPS. Finally, knockdown of TRIL using small interfering RNA attenuates LPS signaling and cytokine production in cell lines, human PBMC, and primary murine mixed glial cells. These results demonstrate that TRIL is a novel component of the TLR4 complex which may have particular relevance for the functional role of TLR4 in the brain.
Paulina Wochal, Vijay Rathinam, Aisling Dunne, Thaddeus Carlson, Wen Kuang, Katherine J. Seidl, J. Perry Hall, Lih‐Ling Lin, Mary Collins, Stefan A. Schattgen, Christopher R. MacKay, Caio T. Fagundes, Susan P. Carpenter, Katherine A. Fitzgerald, Luke O'neill
Maria González-Pérez, Jana Baranda, Leticia Pérez‐Rodríguez, Patricia Conde, Carlos de la Calle‐Fabregat, Marcos J. Berges-Buxeda, Alexander G. Dimitrov, Javier Arranz, Sergio Rius‐Rocabert, Alessia Zotta, Ana Dopazo, Nikita Poddar, Xuedi Wang, Estanislao Nistal‐Villán, Raphaël Duivenvoorden, Joren C. Madsen, David L. Williams, Dan Hasson, Daniel Lozano‐Ojalvo, Florent Ginhoux, Luke O'neill,
Discussion(0)
No comments yet. Be the first to comment.